Serum markers of refractoriness and enteropathy-associated t-cell lymphoma in coeliac disease

Marco Vincenzo Lenti, Nicola Aronico, Paolo Giuffrida, Valentina Antoci, Giovanni Santacroce, Alessandro Vanoli, Catherine Klersy, Gino Roberto Corazza, Antonio Di Sabatino

Research output: Contribution to journalArticlepeer-review

Abstract

The persistence or recurrence of symptoms in patients with coeliac disease (CD), despite a gluten-free diet (GFD), must prompt further work-up for excluding refractory CD (RCD). The aim of this study was to assess the accuracy of serum markers in predicting refractoriness in CD patients. This study included 72 patients affected by CD followed-up at our center, namely 49 uncomplicated CD before and after GFD and 23 RCD. Serum levels of chromogranin A (CgA) and β2-microglobuline were measured at baseline and at follow-up (median time of 13 months) in each group of patients. Cut-off points for each marker were estimated to differentiate RCD from uncomplicated CD patients. Serum levels of CgA and β2-microglobuline were significantly higher in patients with RCD compared to uncomplicated CD (p < 0.001), both at baseline and at follow-up, with no significant difference between RCD type 1 and type 2. The estimated cut-off point for CgA was 90.2 ng/mL (sensitivity 83%, specificity 100%), while for β2-microglobuline it was 696 mcg/L (sensitivity 100%, specificity of 100%). To conclude, CgA and β2-microglobuline could be useful serological markers of refractoriness in CD, with the ability to discriminate those patients who should undergo upper gastrointestinal endoscopy for making a definite diagnosis.

Original languageEnglish
Article number2289
JournalCancers
Volume13
Issue number10
DOIs
Publication statusPublished - May 2 2021

Keywords

  • Chromogranin A
  • Refractory coeliac disease
  • Serum markers
  • β2-microglobuline

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Serum markers of refractoriness and enteropathy-associated t-cell lymphoma in coeliac disease'. Together they form a unique fingerprint.

Cite this